<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00421499</url>
  </required_header>
  <id_info>
    <org_study_id>ECA-02-005</org_study_id>
    <nct_id>NCT00421499</nct_id>
  </id_info>
  <brief_title>Effects of Cocoa Intake on Blood Pressure in Elderly Individuals With Mild Hypertension</brief_title>
  <official_title>Randomized Controlled, Parallel Group, Single Blinded, Phase 1 Study That Investigates the Effects of Regular Daily Intake of Small Amounts of Dark or White Chocolate on Blood Pressure in Elderly Individuals With Mild Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <brief_summary>
    <textblock>
      Regular intake of cocoa-containing foods is linked to a considerably lower cardiovascular and&#xD;
      all-cause mortality in observational studies. Short-term intervention studies indicate that&#xD;
      high doses of cocoa improve endothelial function and reduce blood pressure (BP), but the&#xD;
      clinical impact of long-term intake of small dietary amounts of cocoa on BP and the&#xD;
      underlying BP lowering mechanisms are unclear. We hypothesized that cocoa consumption lowers&#xD;
      blood pressure by augmentation of the circulating vasodilative nitric oxide (NO) pool due to&#xD;
      the action of the cocoa polyphenols at the vascular endothelium.&#xD;
&#xD;
      To test this hypothesis, we will conduct a randomized single-blind, parallel group study in&#xD;
      subjects with mild essential hypertension to evaluate the effects of polyphenol-rich dark&#xD;
      chocolate versus polyphenol-free white chocolate on blood pressure and plasma levels of cocoa&#xD;
      phenols, circulating bioactive nitric oxide, and plasma markers of oxidative stress. After a&#xD;
      7 day cocoa-free run-in period, 44 subjects will be 1:1 randomized to receive over 18 weeks&#xD;
      daily doses of either dark chocolate (6.3 g per day with a total of 30 mg of polyphenols and&#xD;
      30 kcal) or polyphenol free white chocolate (5.6 g per day with 30 kcal, containing similar&#xD;
      amounts of macronutrients, electrolytes and vitamins). Subjects will be counseled to maintain&#xD;
      an isocaloric diet and to abstain from other cocoa products during the study. Blood pressure&#xD;
      and plasma parameters will be assessed in each subject after the run-in period and after 6,&#xD;
      12, and 18 weeks of treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date>May 2005</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in systolic and diastolic blood pressure</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma levels of bioactive nitric oxide, 8-isoprostane, cocoa polyphenols</measure>
  </secondary_outcome>
  <enrollment>44</enrollment>
  <condition>Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dark chocolate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects between the ages of 55 - 75 years in good general health with high normal&#xD;
             blood pressure (between 130/80 and 140/90 mmHg) or mild hypertension (blood pressure&#xD;
             between 140/90 and 160/100 mmHg)on no medication or nutritional supplements&#xD;
&#xD;
          -  Non-manual workers with a household income &gt; 20,000 â‚¬/year&#xD;
&#xD;
          -  Normal plasma lipids (total plasma cholesterol &lt; 6.18 mmol/L&#xD;
&#xD;
          -  LDL &lt; 4.11 mmol/L&#xD;
&#xD;
          -  HDL &gt; 0.9 mmol/L&#xD;
&#xD;
          -  Triacylglycerols &lt; 1.8 mmol/L) and normal plasma glucose (fasting plasma glucose&#xD;
             4.2-6.4 mmol/L).&#xD;
&#xD;
          -  If a subject's blood pressure exceeds 170/100 mmHg on a single visit, the subject will&#xD;
             be withdrawn from the study and referred to appropriate antihypertensive therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Subjects are excluded if they have:&#xD;
&#xD;
          -  Cardiovascular diseases (other than hypertension)&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Hyper-/dyslipidemia&#xD;
&#xD;
          -  Gastrointestinal diseases&#xD;
&#xD;
          -  Hepatic and renal disorders&#xD;
&#xD;
          -  Pulmonary diseases&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Cancer&#xD;
&#xD;
          -  Psychiatric disorders&#xD;
&#xD;
          -  Alcohol or drug dependence&#xD;
&#xD;
          -  Seizure disorders&#xD;
&#xD;
          -  History of organ transplantation&#xD;
&#xD;
          -  Surgery within the last 12 months&#xD;
&#xD;
          -  Positive tests for HIV, hepatitis B or C.&#xD;
&#xD;
        Subjects are excluded if they have:&#xD;
&#xD;
          -  A body-mass index of more than 27.5 or less than 18.5 kg/m2&#xD;
&#xD;
          -  Actively smoked tobacco within the last five years&#xD;
&#xD;
          -  Regularly use medications&#xD;
&#xD;
          -  Used any medication within the last two weeks before entry&#xD;
&#xD;
          -  Use vitamin, mineral or polyphenol supplements or functional food.&#xD;
&#xD;
        Subjects will be excluded if they are unable to give informed consent for all procedures;&#xD;
        or subjects who are not capable or willing to appear for controlling visits.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dirk Taubert</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pharmacology, University of Cologne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Pharmacology, University of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Taubert D, Berkels R, Roesen R, Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA. 2003 Aug 27;290(8):1029-30.</citation>
    <PMID>12941673</PMID>
  </reference>
  <verification_date>January 2007</verification_date>
  <study_first_submitted>January 11, 2007</study_first_submitted>
  <study_first_submitted_qc>January 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2007</study_first_posted>
  <last_update_submitted>January 11, 2007</last_update_submitted>
  <last_update_submitted_qc>January 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

